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Introduction
Smoking, a known myocardial infarction risk factor. It 
influences various mechanisms, which can accelerate 
atherogenesis and it has been confirmed that is related to 
active smoking [1]. Smoking and cardiovascular disease 
have a strong relationship, where a study confirmed the total 
cholesterol, Low-Density Lipoprotein (LDL) cholesterol 
and Triglyceride (TG) tend to be elevated and the HDL 
level decreased in smokers [2]. In another study, the total 
cholesterol and TG rates decrease following cessation of 
smoking [3]. The exact process by which cardiovascular 
risk increase is unknown. The cause of smoking sickness 
is most likely due to these harmful and carcinogenic 
chemicals, because of tobacco contains around 5000 
of chemical materials [4]. It has been revealed that the 
common smoking-related disease includes cardiovascular 
disease, chronic obstructive disease and lung cancer [5]. In 
addition, nicotine is the key ingredient of cigarette smoke, 
which is an alkaloid derived from nicotine tobacco leaves 
that activates the body [6]. Cigarette use is associated 
and effects on the lipid profile thereby raising the risk 
of Coronary Heart Disease (CHD), atherosclerosis and 
atherosclerosis [3].
There are different mechanisms, which causes alteration 
in lipid by smoking for example (nicotine). In general, the 
nicotine leads to increase secretion of hepatic free fatty 
acids and Triglycerides (TG) in the bloodstream together 
with Very-low-Density Lipoprotein-Cholesterol (VLDL-C) 
by increasing catecholamine secretion. Then it leads to 
stimulate sympathetic adrenal and causes an increase in 
lipolysis in the body. A cigarette smoking is also considered 
Background: There are few studies demonstrated the association between smoking and lipid profile 
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Materials and Methods: This study conducted to determine and compare the serum lipid profile 
of female adult smokers with non-female smokers, known as controls. In 180 female subjects, the 
level of serum lipid profile measured. 
Results: Of these, 110 were smokers and 70 non-smokers (control) aged between 25 and 50 years. 
The study involved only smokers who had smoked for more than 5 years. Our result revealed that 
mean serum of total cholesterol (275.2 ± 32.6 mg/dl), triacylglycerol (188.4 ± 56.42 mg/dl), very 
low density lipoprotein (36.6 ± 14.2 mg/dl), low density lipoprotein (133.21 ± 9.81 mg/dl) were 
significantly higher in female smokers as compared to non-female smokers with mean of serum 
total cholesterol (172.3 ± 18.6 mg/dl), very low density lipoprotein (21.8 ± 9.6 mg/dl), triglyceride 
(108 ± 8.84 mg/dl), low density lipoprotein (94.54 ± 8.5 mg/dl). However, the mean of serum value 
for high density lipoprotein cholesterol in chronic female smokers was lower (44.6 ± 4.6 mg/dl) than 
in non-female smokers (55.3 ± 8.2 mg/dl). 
Conclusion: This study indicated that smoking cigarettes in female cause’s dyslipidemia, resulting 
in increased risk of cardiovascular disease among smokers.
Abstract
Keywords: Cholesterol, LDL, HDL, Smoking.
Accepted on November 18, 2020
Analysis of serum lipid profile in adult female smokers in Erbil city, Kurdistan region of Iraq.
Biomed Res 2021 Volume 32 Issue 1
30
to have an increased levels of homocysteine that induces 
oxidative Low-Density Lipoproteins Cholesterol (LDL-C) 
alteration and decreases HDL cholesterol, multiple studies 
have documented homocysteine inhibiting Apolipoprotein 
A1 (APo A-I) which is measure an important protein 
compositions of high-density lipoproteins-cholesterol 
(HDL-C) in plasma [7]. 
Nicotine increases the amount of bad fats in the blood 
vessels for example Total Cholesterol (TC), LDL, and TG, 
it may also decreases the amount of good fat for example 
total lipoprotein cholesterol (HDL-C) [8]. Nicotine 
also induces oxidative stress, creates free radicals that 
target the member lipids following by Malondialdehyde 
(MDA). This MDA can cause peroxidative damage to the 
body tissues [9]. Oxidation of lipoproteins was believed 
to occur in the bloodstream and can create superoxide 
radicals. Hydrogen peroxide or lipid peroxides outside the 
cell may contribute to LDL oxidation [9]. However, there 
is much debate about the components of the lipid profile 
are primarily altered in response to cigarette smoking. It is 
not exactly clear whether certain components of the lipid 
profile directly or indirectly affect other components. 
In this study, we hypothesized and analysed the effect of 
smoking in female community on the lipid profile in Erbil 
city, Kurdistan region of Iraq.
Materials and Methods
In this study, 180 female smokers were evaluated in Erbil 
city, Kurdistan region of Iraq. For this study 110 female 
lifelong smokers who had been smoking for more than 
5 years. Female aged between 25 and 50 years, were 
included as a (Group A). 70 non-smokers in female nearly 
matching in their weigh and age with the female smokers 
in (Group A) were subjected as controls (Group B). The 
control group was considered a healthy and without 
history of smoking that matches the background of cases.
Blood samples were taken on fasting for 10-12 hrs. Each 
blood sample was moved with plastic centrifuge tube to 
Rizgari Teaching Hospital laboratory. For both groups the 
following criteria were used:
1. Ex-smokers 





7. Family history and previous heart disease
8. Hypertension
9. Diabetes mellitus
10. Lipid lowering drug or any drug
Blood serum was collected, centrifuged and then samples 
were subsequently aliquoted and stored at -20 °C until 
analyzed. Levels of lipid profile such as cholesterol, TG, 
LDL-C and HDL-C were examined by Cobas 400 integra 
colorimetric method. The range of normal, and high total 
cholesterol was <200, 200 to 250, >250 mg/dl respectively. 
TG estimation method was based on Wahlefeld's and the 
normal value for TG was <150 mg/dl. Examination of 
LDL-C depends on the cholesterol ester breakdown into 
free cholesterol and cholesterol esterase fatty acids. The 
normal range of LDL-C was <150 mg/dl. The normal 
range of HDL-C was 34-52 mg/dl in females.
Statistics
Statistical analysis was performed by using of IBM SPSS 
Statistics software version 20. Data were presented as mean 
values ± SD. Statistical evaluations were performed by 
the use of t-test. P value ≤ 0.05 was considered significant 
and the difference between mean total cholesterol, TG, 
HDL and LDL levels of the two classes was statistically 
examined by student t-test. 
Results
As shown in Table 1, the levels of Total Cholesterol 
(TC), TG, VLDL-Cholesterol, LDL-Cholesterol, were 
significantly increased in female smokers compared to 
control group. However, the levels of HDL-Cholesterol in 
group A were significantly lower compared to group B. 










TC 275.2 ± 32.6 172.3 ± 18.6 <0.05
TG 188.4 ± 47.6 108 ± 8.84 <0.05
VLDL-
Cholesterol 36.6 ± 14.2 21.8 ± 9.6 <0.05
LDL-
Cholesterol 133.21 ± 9.81 94.54 ± 8.5 <0.05
HDL-
Cholesterol 44.6 ± 4.6 55.3 ± 8.2 <0.05
Discussion
The rate of CHD in female smokers was higher compared 
to non-female smokers in Erbil city. This might due to 
cigarette will leads to increase the levels of lipoprotein. 
According to this rate, we evaluated the levels of 
lipoprotein among female smokers with non-smokers in 
different age. In general, in cigarette smokers the risk of 
CHD is higher than in non-smokers and can be interpreted 
by different interactions among degradation of the 
integrity of Arterial Walls (AW), blood lipid, lipoprotein 
derangements and blood coagulation. The result data of 
lipid profiles such TC, TG, VLDL-C; LDL-C levels in 
smokers of group compared were higher than to non-
smokers in group B with p values as shown in Table 1. 
It may because of nicotine’s, the nicotine leads to secrete 
high levels of Hepatic Free Fatty Acids (HFFA) and TC 
along with VLDL-C in the blood stream by increasing 
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the secretion of catecholamines. This catecholamine’s 
then stimulating sympathetic adrenal system followed 
by in increased lipolysis. Or the spike in lipids in female 
smokers may be because of consuming tobacco induces 
the absorption of nicotine into the bloodstream. This 
absorption may induces lipolysis. Then free fatty acids 
will pass through into the bloodstream via activation of 
adenyl cyclase in the body tissue and then nicotine will 
induces catecholamine secretion [10]. It is important to 
mention that elevated free fatty acids in the liver contribute 
to decreased hepatic TG and VLDL synthesis and it may 
raising the blood production of TG and VLDL-C [11]. 
Our data has also shown a significant reduction in HDLC 
levels (P<0.05) in female smokers compared to non-
female smokers (Table 1). In general, HDL biosynthesis 
involves in synthesis of A-I (Apoa-1) followed by the 
acquisition of liver cholesterol and phospholipids, forming 
nascent HDL particles. Smoking cigarettes can decrease 
the Apoa-I levels. Lack of ApoA-I results in defective 
synthesis of HDLs. Smoking cessation regained attention 
at Apoa-I. This data is in line with many studies that have 
reported high homocysteine plasma levels in smokers 
[12,13], and stated that in plasma homocysteine negatively 
associated with HDL-C and Apo A-I. Increased levels of 
homocysteine may result in decreased levels of HDL-C 
via multiple mechanisms as described by Huang F., et al. 
[12]. Genetic study to evaluate the influence of blood lipid 
levels on the risk CHD are more recommended.
Conclusion
 Smoking-induced can increased release of catecholamine 
may also justify further reduction of HDL-C in lifelong 
smokers, resulting in decreased VLDL-C and reduced 
concentrations of HDL-C. However, our data clearly 
showed a very strong relationship between smoking and 
lipid profile increase. The risk of an increase in serum 
cholesterol in female smokers with an increase in LDLC 
is associated with coronary heart disease.
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